Increased Neutralizing Antibody Response after Simultaneous Immunization with Leucogen and the Feline Leukemia Virus Transmembrane Protein

被引:26
作者
Langhammer, Stefan [1 ]
Fiebig, Uwe [1 ]
Kurth, Reinhard [1 ]
Denner, Joachim [1 ]
机构
[1] Robert Koch Inst, DE-13353 Berlin, Germany
关键词
Feline leukemia virus; Vaccination; Neutralizing antibodies; Transmembrane envelope protein; FELV; INDUCTION; CATS; GP41; TRANSMISSION; VACCINATION; EFFICACY; IMMUNITY; HIV-1; P15E;
D O I
10.1159/000318892
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To develop improved vaccination strategies against feline leukemia virus (FeLV), rats were immunized with the transmembrane envelope protein p15E of FeLV alone or in combination with the commercial vaccine Leucogen (R) comprising the nonglycosylated FeLV surface envelope protein. Binding and neutralizing antibodies were induced in both groups and in the group immunized with Leucogen alone. Higher titers of antibodies neutralizing FeLV were induced by simultaneous immunization with Leucogen and p15E compared to the responses using Leucogen or p15E alone, suggesting that combination vaccines should be used in the future. Epitope mapping of p15E-specific antibodies induced by simultaneous immunization with Leucogen and p15E revealed the same pattern of response as obtained after immunization with p15E alone: one epitope was localized in the membrane-proximal external region (MPER) and the other in the fusion peptide-proximal region, and they are related to the epitopes detected after immunization with p15E of the porcine endogenous retrovirus and the koala retrovirus. The data indicate that these epitopes in the MPER are an effective target for neutralization and that antigens containing them may therefore prove to be a useful component of vaccines against retroviruses, including HIV-1. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:78 / 86
页数:9
相关论文
共 28 条
[1]  
Arita I, 1979, Dev Biol Stand, V43, P283
[2]   Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12 [J].
Armbruster, C ;
Stiegler, GM ;
Vcelar, BA ;
Jäger, W ;
Köller, U ;
Jilch, R ;
Ammann, CG ;
Pruenster, M ;
Stoiber, H ;
Katinger, HWD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (05) :915-920
[3]   In vivo evolution and selection of recombinant feline leukemia virus species [J].
Bechtel, MK ;
Mathes, LE ;
Hayes, KA ;
Phipps, AJ ;
Roy-Burman, P .
VIRUS RESEARCH, 1998, 54 (01) :71-86
[4]   Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? [J].
Fiebig, U ;
Stephan, O ;
Kurth, R ;
Denner, J .
VIROLOGY, 2003, 307 (02) :406-413
[5]   Transspecies transmission of the endogenous koala retrovirus [J].
Fiebig, Uwe ;
Hartmann, Manuel Garcia ;
Bannert, Norbert ;
Kurth, Reinhard ;
Denner, Joachim .
JOURNAL OF VIROLOGY, 2006, 80 (11) :5651-5654
[6]   Feline leukaemia virus: protective immunity is mediated by virus-specific cytotoxic T lymphocytes [J].
Flynn, JN ;
Hanlon, L ;
Jarrett, O .
IMMUNOLOGY, 2000, 101 (01) :120-125
[7]   Genetic evidence that interhelical packing interactions in the gp41 core are critical for transition of the human immunodeficiency virus type 1 envelope glycoprotein to the fusion-active state [J].
Follis, KE ;
Larson, SJ ;
Lu, M ;
Nunberg, JH .
JOURNAL OF VIROLOGY, 2002, 76 (14) :7356-7362
[8]  
HALEY PJ, 1985, JNCI-J NATL CANCER I, V74, P821
[9]   Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors [J].
Hanlon, L ;
Argyle, D ;
Bain, D ;
Nicolson, L ;
Dunham, S ;
Golder, MC ;
McDonald, M ;
McGillivray, C ;
Jarrett, O ;
Neil, JC ;
Onions, DE .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8424-8433
[10]   Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays [J].
Hofmann-Lehmann, R ;
Tandon, R ;
Boretti, FS ;
Meli, ML ;
Willi, B ;
Cattori, V ;
Gomes-Keller, MA ;
Ossent, P ;
Golder, MC ;
Flynn, JN ;
Lutz, H .
VACCINE, 2006, 24 (08) :1087-1094